Groups

Research Focus

Former Employee. Pediatrics; Nurse Practitioner

Recent additions – View all

1. A novel capecitabine dosing schedule combined with bevacizumab is safe and active in patients with metastatic breast cancer: A phase II study

   Meeting Abstract

   Traina, T. A.; Theodoulou, M.; Dugan, U.; Feigin, K.; Patil, S.; Edwards, C.; Norton, L.; Hudis, C. A.
   Journal of Clinical Oncology (2008)

   Fulltext@MSK | Save
2. Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancer

   Journal Article

   Traina, T. A.; Theodoulou, M.; Feigin, K.; Patil, S.; Tan, L. K.; Edwards, C.; Dugan, U.; Norton, L.; Hudis, C.
   Journal of Clinical Oncology (2008)

   Fulltext@MSK | Save
3. Phase I study of a novel capecitabine schedule based on Norton-Simon mathematical modeling

   Meeting Abstract

   Theodoulou, M.; Traina, T. A.; Dugan, U.; Lake, D.; Fornier, M.; Feigin, K.; Patil, S.; Edwards, C.; Norton, L.; Hudis, C. A.
   Journal of Clinical Oncology (2007)

   Fulltext@MSK | Save